BIOLASE Inc. (BIOL): Market Cap to Revenue

Symbol and logo of brand BIOLASE Inc. (BIOL)

BIOLASE, Inc. (BIOL) ensures precision equipment assembly in compliance with RoHS standards. The cost-to-sales ratio reflects the current market valuation, where the parameter is 0.00. Leadership in the painless treatment niche with Waterlase makes the brand's systems highly sought after in premium clinics, while the implementation of energy-efficient production cycles and the minimization of plastic confirm the company's commitment to environmental responsibility.

BIOL BIOLASE Inc. P/S Multiple (07/04/2022 - 08/04/2024)

Analytical breakdowns for Biolase, Inc. (BIOL)

- share price and consensus valuation forecast:
Price Performance Chart biolase.com|BIOL - Price Target Chart
- stock exchange capitalization data:
Market Valuation Biolase, Inc.|BIOL - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share BIOLASE|BIOL - Book Capitalization|Capitalization to Book Value Ratio biolase.com|BIOL - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient BIOLASE, Inc.|BIOL - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Biolase Inc.|BIOL - Company Aggregate Debts|Debts to Book Capitalization Biolase, Inc.|BIOL - Company Long-Term Debt|Company Short-Term Debt BIOLASE|Intermediate Coverage Ratio biolase.com
- earnings and multiples data:
BIOL - Net Profit|Expected Net Profit BIOLASE, Inc.|BIOL - Price to Earnings Ratio|Forward Price to Earnings Multiple BIOLASE Inc.|BIOL - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Biolase, Inc.|BIOL - Operating profit EBITDA|Net earnings per share for the last four quarters BIOLASE|BIOL - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months biolase.com|BIOL - Earnings per share growth in current year|Expected earnings per share growth for next year BIOLASE, Inc.
- issuer revenue and sales details:
BIOL - Revenue and Sales Volume|Company Expected Sales Volume biolase.com|BIOL - Price-to-Revenue Ratio|Market Cap to Projected Revenue Biolase, Inc.
General company analysis:BIOL biolase.com
Core merchandise of BIOLASE, Inc.

The P/S multiple determines the market value of one dollar of revenue, allowing an investor to assess the degree of overpayment for a business regardless of current profitability. By analyzing the price-to-sales ratio, one can understand the premium at which the market values the leadership of BIOLASE (BIOL) in the painless dental laser segment and the willingness of capital to pay for exceptional brand authority.

Competitors of BIOLASE, Inc.

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Price-to-Revenue Multiple|Bioventus Corp - Market Cap to Revenue|P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - P/S Multiple|Price-to-Revenue Coefficient blade.com SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Inc)|Price-to-Revenue Ratio ClearPoint Neuro Inc.|Market Cap to Revenue Stereotaxis Corporation (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Revenue Ratio|NSPR: Market Cap to Revenue|Jin Medical International - Market Cap to Sales Volume|VANI: P/S Multiple|XTNT (Xtant Medical) - Price-to-Revenue Ratio|NMTC (NeuroOne Medical Technologies Corporation) - P/S Multiple|Modular Med (MODD) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Myomo, Inc (MYO)|COCH - Price to Sales|Price-to-Revenue Ratio Vivos Therapeutics VVOS|envveno.com - Price-to-Revenue Ratio|SINTX Technologies - P/S Multiple|TNON - P/S Multiple|ReWalk Robotics Ltd (LFWD) - Price-to-Revenue Ratio|AMIX - Price-to-Revenue Coefficient|IVF (INVO Fertility Inc) - P/S Multiple|Price to Sales bonebiologics.com BBLG|Market Cap to Revenue AXNX (Axonics)|DYNT (dynatronics.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple FNA (Paragon 28)|Price-to-Revenue Coefficient INVO Bioscience Inc. (INVO)